EF-Education First-Drapac rider Joe Dombrowksi feels there is no clear cut answer to the rights and wrongs of Chris Froome`s decision to continue with a normal race program despite the Briton`s Adverse Analytical Finding for salbutamol during the 2017 Vuelta a Espana. The American rider also believes that Froome`s case highlights the economic vulnerability of a sport which depends totally on sponsorship deals for financial survival. But at the same time, Dombrowski, a former Team Sky rider, recognises that Froome has the right to race and that not enough is known for the case to be evaluated fully for or against that decision. `If I was a major corporation, looking at backing cycling , and the biggest rider in the sport is under investigation and racing, and it was not sure whether he`s going to get banned and then they are going to have to take away results he`s achieved, the whole look is a bit messy if you`re trying to sell that,` Dombrowski told Cyclingnews.ADVERTISEMENT However, he also points that, `I don`t really know the details of the case, I don`t think anybody apart from Chris and probably some people at Sky do.` `So I guess I don`t have a really strong opinion either way. I don`t think it`s a good look for the sport in general, which is the only reason I`d say I`m not sure it`s great that he`s racing, but I don`t know all the details, I don`t know that that`s his fault. There`s so much we don`t know.` Froome`s urine sample from an anti-doping control taken after stage 18 of the 2017 Vuelta a Espana was found to have twice the allowed limit of the asthma drug salbutamol. The 32-year-old says he is a life-long asthma sufferer, and insisted that he knows the rules and has never taken more than he is allowed. Gunning for the Giro d`Italia after a good winter
You can read more at Cyclingnews.com
|
